Metagenomi: Sarah Noonberg

Sarah Noonberg has been appointed as chief medical officer of gene editing company Metagenomi. Previously, she was CMO at Maze Therapeutics, and before that, CMO at Nohla Therapeutics. Noonberg holds an MD from the University of California, San Francisco, a PhD in bioengineering from the University of California, Berkeley, and a BS in engineering science from Dartmouth College.